Provided by Tiger Trade Technology Pte. Ltd.

EDDING GENOR

1.495
+0.0302.05%
Volume:167.50K
Turnover:242.54K
Market Cap:2.97B
PE:5.45
High:1.495
Open:1.465
Low:1.420
Close:1.465
52wk High:5.600
52wk Low:1.420
Shares:1.99B
HK Float Shares:1.99B
Volume Ratio:0.24
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.274
ROE:12.75%
ROA:6.60%
PB:0.66
PE(LYR):5.45
PS:1.02

Loading ...

Company Profile

Company Name:
EDDING GENOR
Exchange:
SEHK
Establishment Date:
2001
Employees:
- -
Office Location:
Building 1,Room 406,No. 36 Doukou Road,Hengqin New Area,Zhuhai,Guangdong Province,China
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Edding Genor Group Holdings Ltd, formerly Genor Biopharma Holdings Ltd, is a company primarily engaged in the biopharmaceuticals business. The Company’s main business is engaged in the discovery, development and commercialization of biopharmaceutical products for human use. The Company’s product pipelines include Lerociclib (GB491), GB261, GB263T, Infliximab (GB242), Coprelotamab (GB221), GB223, Rituximab (GB241) and other products, covering disease fields such as breast cancer, lung cancer, gastrointestinal tumors, and blood tumors. The Company mainly conducts its businesses in the domestic market.

Directors

Name
Position
Ni Xin
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
HAN Shu Hua
Executive Director
YU Tie Ming
Director,Audit Committee Member
David Guowei Wang
Director,Member of the Remuneration and Assessment Committee
Wen Chen
Independent Director,Member of the Remuneration and Assessment Committee
XU Qing
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
ZHENG Jing Jing
Independent Director,Member of the Nomination Committee,Audit Committee Chairman

Shareholders

Name
Position
Ni Xin
CEO
XIE Han Qing
Vice General Manager
WENG Zhi Bing
Vice General Manager
WENG Cheng Yi
CFO,Board Secretary
XIE Cui Mei
Corporate Secretary
WANG Qian Hui
Corporate Secretary
HAN Shu Hua
Chief Science Officer
CHEN Zi
Other Senior Executives
ZHOU Qiong
Other Senior Executives
DI Jing
Other Senior Executives